Incidence and Characteristics of Infectious Complications in Multiple Myeloma Patients Treated With Bispecific Antibodies
Authors:
- Taekeun ParkTPTaekeun Park
- Sukjin JangSJSukjin Jang
- Youngil KohYKYoungil Koh
- Dong-Yeop ShinDSDong-Yeop Shin
- Sung-Soo YoonSYSung-Soo Yoon
- Chan Mi LeeCLChan Mi Lee
- Hyeon Jae JoHJHyeon Jae Jo
- Pyoeng Gyun ChoePCPyoeng Gyun Choe
- Wan Beom ParkWPWan Beom Park
- Nam Joong KimNKNam Joong Kim
- Chang Kyung KangCKChang Kyung Kang
- Ja Min ByunJBJa Min Byun
Open Access
- 1 January 2025
- journal article
- infectious diseases
- Published by XMLink in Journal of Korean Medical Science
- Vol. 40 (20)
Abstract
Park T, et al. J Korean Med Sci. 2025 Feb;40:e86. https://doi.org/10.3346/jkms.2025.40.e86Keywords
This publication has 25 references indexed in Scilit:
- Bispecific antibodies for multiple myeloma: past, present and futureInternational Journal of Hematology, 2024
- Characteristics and incidence of infections in patients with multiple myeloma treated by bispecific antibodies: a national retrospective studyClinical Microbiology and Infection, 2024
- Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panelBlood Cancer Journal, 2023
- Clinical outcomes of chemotherapy in cancer patients with different ethnicitiesCancer Reports, 2023
- Infectious complications of bispecific antibody therapy in patients with multiple myelomaBlood Cancer Journal, 2023
- Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working GroupThe Lancet Haematology, 2022
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJAMA, 2020
- ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector CellsTransplantation and Cellular Therapy, 2019
- Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell TransplantationNew England Journal of Medicine, 2014
- Efficacy of a Viral Load-Based, Risk-Adapted, Preemptive Treatment Strategy for Prevention of Cytomegalovirus Disease after Hematopoietic Cell TransplantationTransplantation and Cellular Therapy, 2012